From Metabolic Syndrome to Cardiovascular–Kidney–Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction

The landscape of metabolic health has evolved dramatically in recent years. Once viewed as a collection of distinct conditions, disorders like obesity, type 2 diabetes, cardiovascular disease, chronic kidney disease, and fatty liver disease are now understood to share common pathophysiological roots. This review explores the transition from the traditional concept of metabolic syndrome toward more comprehensive and clinically relevant frameworks, namely, the cardiovascular-kidney-metabolic (CKM) syndrome proposed by the American Heart Association, and the systemic metabolic disorder (SMD) framework introduced by the European Atherosclerosis Society. Both models recognize the progressive, multisystemic nature of metabolic dysfunction, highlight the need for stage-based risk stratification, and emphasize early intervention. The authors discuss the central role of dysfunctional adiposity and ectopic fat in driving organ-specific damage, and examine the growing body of evidence supporting the use of novel therapies such as sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RA), and gastric inhibitory polypeptide (GIP)/GLP-1RA in delivering multiorgan protection. By comparing the CKM and SMD models, the authors highlight their complementary nature and shared call for a shift in clinical thinking away from isolated management and toward integrated, multidisciplinary care. As the burden of metabolic dysfunction continues to rise, the need to recognize obesity as a chronic disease and to develop practical, collaborative strategies across cardiology, nephrology, endocrinology, and hepatology becomes even more urgent. The rise of cardiometabolic medicine offers a timely and necessary response to this growing challenge, creating opportunities for better prevention, earlier detection, and improved outcomes for the patients.

Authors

Institutions

Publication Details

Journal
The Anatolian Journal of Cardiology
Published
2025-01-01
DOI
https://doi.org/10.14744/anatoljcardiol.2025.5602
Citations
4
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
3.49
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Metabolic Syndrome to Cardiovascular–Kidney–Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction

Nil Özyüncü
4 citations
The Anatolian Journal of Cardiology
Diet and metabolism studies
3.49
article

From Metabolic Syndrome to Cardiovascular–Kidney–Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction

Nil Özyüncü
article en
4 citations

Abstract

The landscape of metabolic health has evolved dramatically in recent years. Once viewed as a collection of distinct conditions, disorders like obesity, type 2 diabetes, cardiovascular disease, chronic kidney disease, and fatty liver disease are now understood to share common pathophysiological roots. This review explores the transition from the traditional concept of metabolic syndrome toward more comprehensive and clinically relevant frameworks, namely, the cardiovascular-kidney-metabolic (CKM) syndrome proposed by the American Heart Association, and the systemic metabolic disorder (SMD) framework introduced by the European Atherosclerosis Society. Both models recognize the progressive, multisystemic nature of metabolic dysfunction, highlight the need for stage-based risk stratification, and emphasize early intervention. The authors discuss the central role of dysfunctional adiposity and ectopic fat in driving organ-specific damage, and examine the growing body of evidence supporting the use of novel therapies such as sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RA), and gastric inhibitory polypeptide (GIP)/GLP-1RA in delivering multiorgan protection. By comparing the CKM and SMD models, the authors highlight their complementary nature and shared call for a shift in clinical thinking away from isolated management and toward integrated, multidisciplinary care. As the burden of metabolic dysfunction continues to rise, the need to recognize obesity as a chronic disease and to develop practical, collaborative strategies across cardiology, nephrology, endocrinology, and hepatology becomes even more urgent. The rise of cardiometabolic medicine offers a timely and necessary response to this growing challenge, creating opportunities for better prevention, earlier detection, and improved outcomes for the patients.

The Anatolian Journal of CardiologyVol. 29(8)
Ankara University (TR)
Openalex Percentile: Top 7%
Diet and metabolism studies
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From Metabolic Syndrome to Cardiovascular–Kidney–Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction — Nil Özyüncü · The Anatolian Journal of Cardiology (2025) | TGRS Research Map | TGRS